Sang Wun Kim

Prof. Dr. Sang Wun Kim

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
ENEun Ji Nam
Eun Ji Nam
HYHeejei Yoon
Heejei Yoon
SKSang Wun Kim
Sang Wun Kim
HKHoguen Kim
Hoguen Kim
Do Young KimDo Young Kim
Do Young Kim
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim
Purpose: Although microRNAs have recently been recognized as riboregulators of gene expression, little is known about microRNA expression profiles in serous ovarian carcinoma. We assessed the expression of microRNA and the association between microRNA expression and the prognosis of serous ovarian carcinoma. Experimental Design: Twenty patients diagnosed with serous ovarian carcinoma and eight patients treated for benign uterine disease between December 2000 and September 2003 were enrolled in this study. The microRNA expression profiles were examined using DNA microarray and Northern blot analyses. Results: Several microRNAs were differentially expressed in serous ovarian carcinoma compared with normal ovarian tissues, including miR-21, miR-125a, miR-125b, miR-100, miR-145, miR-16, and miR-99a, which were each differentially expressed in >16 patients. In addition, the expression levels of some microRNAs were correlated with the survival in patients with serous ovarian carcinoma. Higher expression of miR-200, miR-141, miR-18a, miR-93, and miR-429, and lower expression of let-7b, and miR-199a were significantly correlated with a poor prognosis (P < 0.05). Conclusion: Our results indicate that dysregulation of microRNAs is involved in ovarian carcinogenesis and associated with the prognosis of serous ovarian carcinoma.

15 April 2008 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
HCHanbyoul Cho
Hanbyoul Cho
HHHye Won Hur
Hye Won Hur
SKSang Wun Kim
Sang Wun Kim
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim
Jae-Hoon KimJae-Hoon Kim
Jae-Hoon Kim
KLKook Lee
Kook Lee

17 November 2014 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
HKHee Jung Kim
Hee Jung Kim
DLDae Woo Lee
Dae Woo Lee
GYGa Won Yim
Ga Won Yim
ENEun Ji Nam
Eun Ji Nam
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim
Do Young KimDo Young Kim
Do Young Kim
The functions of many long non-coding RNAs (lncRNAs) in human cancers remain to be clarified. The lncRNA Hox transcript antisense intergenic RNA (HOTAIR) has been reported to reprogram chromatin organization and promote breast and colorectal cancer metastasis, the involvement of lncRNAs in cervical cancer is just beginning to be studied. In the present study, we examined the expression and the functional role of HOTAIR in cervical cancer. HOTAIR expression was determined in cervical cancer tissues (n=111) and corresponding normal tissues (n=40) by using real-time polymerase chain reaction, and its correlation with clinical parameters and prognosis were analyzed. To determine the effect of HOTAIR knockdown and overexpression in cervical cancer cell lines, we used the CCK-8 assay, wound healing migration and matrigel invasion assay. The expression level of HOTAIR in cervical cancer tissues was higher than that in corresponding non-cancerous tissues. High HOTAIR expression correlated with lymph node metastasis, and reduced overall survival. A multivariate analysis showed that HOTAIR was a prognostic factor for predicting cervical cancer recurrence. Knockdown of HOTAIR reduced cell proliferation, migration, and invasion in cervical cancer cell lines. Moreover, HOTAIR regulated the expression of vascular endothelial growth factor, matrix metalloproteinase-9 and epithelial-to-mesenchymal transition (EMT)-related genes, which are important for cell motility and metastasis. Therefore, HOTAIR may promote tumor aggressiveness through the upregulation of VEGF and MMP-9 and EMT-related genes. These findings indicate that HOTAIR may represent a novel biomarker for predicting recurrence and prognosis and serve as a promising therapeutic target in cervical cancer.

1 March 2010 in Gynecologic Oncology
Verified
Journal Article
Closed access
ENEun Ji Nam
Eun Ji Nam
MYMijin Yun
Mijin Yun
YOYoung Taik Oh
Young Taik Oh
JKJae Wook Kim
Jae Wook Kim
Jae-Hoon KimJae-Hoon Kim
Jae-Hoon Kim
Do Young KimDo Young Kim
Do Young Kim

1 July 2010 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
GYGa Won Yim
Ga Won Yim
YJYONG WOOK JUNG
YONG WOOK JUNG
JPJiheum Paek
Jiheum Paek
SLSan Hui Lee
San Hui Lee
HKHa Yan Kwon
Ha Yan Kwon
SKSang Wun Kim
Sang Wun Kim

1 February 2008 in Gynecologic Oncology
Verified
Journal Article
Closed access
Do Young KimDo Young Kim
Do Young Kim
SKSang Wun Kim
Sang Wun Kim
WHWoo Jin Hyung
Woo Jin Hyung
SLSoo Jin Lee
Soo Jin Lee
ENEun Ji Nam
Eun Ji Nam
WLWoo Jung Lee
Woo Jung Lee